CLINICAL_TRIALS
trial_result
· 2023-05-06
Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Summary
Phase 2 clinical trial of EYP001a in nonalcoholic steatohepatitis completed; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Enyo Pharma | Conditions: Non-alcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-05-06